Pernod Ricard


FY20 guidance cut due to Coronavirus

13/02/20 -"A strong H1 FY20 has beaten the PRO expectations, while the FY20 guidance has been cut (purely) on the Coronavirus troubles. The market finally paid for the group’s transparency about the ..."

Pages
51
Language
English
Published on
13/02/20
You may also be interested by these reports :
23/10/25
Kerry Group delivered Q3 2025 volume growth of 3%, broadly in line with Visible Alpha consensus of +3.1%. Growth was supported by strong performances ...

22/10/25
Heineken has reported organic results in line with expectations. The Eastern region has partially offset challenges in the Western region, which is ...

16/10/25
Pernod Ricard reported a slightly larger-than-expected organic decline in Q1 25/26, impacted by ongoing destocking and soft consumer demand. However, ...

15/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO